Both in Pharmaceuticals
Benitec Biopharma vs Arcturus Therapeutics Holdings
Over the past year BNTC returned −46.6% and ARCT returned +10.6%; their daily moves had a correlation of 0.36.
BNTC −46.6% ARCT +10.6%Growth of $1, one year, split-adjusted
| Metric | BNTC | ARCT |
|---|---|---|
| Price | $8.74 | $11.03 |
| Market cap | $304.9M | $313.5M |
| Today | −1.02% | −9.22% |
| 1 month | −8.8% | −16.5% |
| 6 months | −26.9% | +27.8% |
| Year to date | −35.1% | +79.9% |
| 1 year | −45.9% | +16.8% |
| Revenue growth (YoY) | — | −89.5% |
| Gross margin | — | 100.0% |
| Net margin | — | −803.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 10.7× |
| Net cash | $180.0M | $191.5M |
| Dividend yield | — | — |
| Volatility (60d) | 56.5% | 114.9% |
| Short % of float | 9.4% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).